2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
Khera R, Dhingra L, Aminorroaya A, Li K, Zhou J, Arshad F, Blacketer C, Bowring M, Bu F, Cook M, Dorr D, Duarte-Salles T, DuVall S, Falconer T, French T, Hanchrow E, Horban S, Lau W, Li J, Liu Y, Lu Y, Man K, Matheny M, Mathioudakis N, McLemore M, Minty E, Morales D, Nagy P, Nishimura A, Ostropolets A, Pistillo A, Posada J, Pratt N, Reyes C, Ross J, Seager S, Shah N, Simon K, Wan E, Yang J, Yin C, You S, Schuemie M, Ryan P, Hripcsak G, Krumholz H, Suchard M. Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM. BMJ Medicine 2023, 2: e000651. PMID: 37829182, PMCID: PMC10565313, DOI: 10.1136/bmjmed-2023-000651.Peer-Reviewed Original ResearchType 2 diabetes mellitusSecond-line treatmentCardiovascular risk groupsDiabetes mellitusCardiovascular diseaseAntihyperglycaemic drugsLine treatmentRisk groupsObservational Health Data SciencesGlucagon-like peptide-1 receptor agonistsElectronic health recordsSodium-glucose cotransporter 2 inhibitorsCalendar year trendsPeptide-1 receptor agonistsUS databaseOutcomes of patientsCotransporter 2 inhibitorsAdministrative claims databaseSecond-line drugsHealth recordsSodium-glucose cotransporter-2 inhibitorsMedication useMetformin monotherapyGuideline recommendationsOutcome measuresIncreased risk of depression in patients with discoid lupus erythematosus: a nested, case–control study in the All of Us Research Program
Chen G, Shaw K, Sanchez-Melendez S, Vleugels R, Cohen J. Increased risk of depression in patients with discoid lupus erythematosus: a nested, case–control study in the All of Us Research Program. British Journal Of Dermatology 2023, 189: 628-629. PMID: 37461222, DOI: 10.1093/bjd/ljad239.Peer-Reviewed Original ResearchConceptsDiscoid lupus erythematosusCase-control studyRisk of depressionLupus erythematosusMajor depressive disorderHealth Research programmeDepressive disorderUs Research ProgramPatientsUS databaseLarge-scale studiesNational InstituteErythematosusRiskHeterogeneous populationDepressionFirst large-scale studyDemographic groups
2022
35151 The association of major depressive disorder and anxiety with granuloma annulare: A case-control study of the NIH All of Us database
Belzer A, Leasure A, Damsky W. 35151 The association of major depressive disorder and anxiety with granuloma annulare: A case-control study of the NIH All of Us database. Journal Of The American Academy Of Dermatology 2022, 87: ab116. DOI: 10.1016/j.jaad.2022.06.498.Peer-Reviewed Original Research
2016
Pediatric Contact Dermatitis Registry Inaugural Case Data
Goldenberg A, Mousdicas N, Silverberg N, Powell D, Pelletier JL, Silverberg JI, Zippin J, Fonacier L, Tosti A, Lawley L, Chang M, Scheman A, Kleiner G, Williams J, Watsky K, Dunnick CA, Frederickson R, Matiz C, Chaney K, Estes TS, Botto N, Draper M, Kircik L, Lugo-Somolinos A, Machler B, Jacob SE. Pediatric Contact Dermatitis Registry Inaugural Case Data. Dermatitis 2016, 27: 293-302. PMID: 27649353, DOI: 10.1097/der.0000000000000214.Peer-Reviewed Original ResearchConceptsPositive patch testsAllergic contact dermatitisPediatric allergic contact dermatitisRelevant positive patch testPatch test resultsUS childrenPatch testEpicutaneous patch testingFragrance mix IBalsam of PeruPercent of casesHealth care providersCommon allergensRegistry databasePatch testingContact dermatitisDiagnostic confirmationRetrospective analysisCare providersMix IUS databaseHigh rateAllergensChildrenFirst year
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply